Kalvista Pharmaceuticals Inc Cash Flow Reinvestment Rate

Latest as of January 2018: 0.01x

Kalvista Pharmaceuticals Inc cash flow reinvestment rate. Kalvista Pharmaceuticals Inc (KALV) has a Cash Flow Reinvestment Rate of 0.01x as of January 2018, reinvesting $182.00K (capex $182.00K ) from operating cash flow of $28.22 Million. See Kalvista Pharmaceuticals Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.01x
(Capex + Investments) / Operating CF

Total Reinvested

$182.00K
Capex + Investments

Operating Cash Flow

$28.22 Million
USD

Capital Expenditures

$182.00K
USD

Cash Flow Reinvestment Rate of Kalvista Pharmaceuticals Inc (2018–2018)

Cash flow reinvestment rate of Kalvista Pharmaceuticals Inc from 2018 to 2018. Historical reinvestment intensity for Kalvista Pharmaceuticals Inc across 1 annual periods. Explore cash flow to debt ratio of Kalvista Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.

Kalvista Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2018–2018)

Kalvista Pharmaceuticals Inc cash flow reinvestment rate by year from 2018 to 2018. Year-by-year capital reinvestment analysis for Kalvista Pharmaceuticals Inc. For the full cash flow conversion analysis, see KALV cash flow metrics.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2018 0.27x $2.85 Million $10.56 Million $1.43 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow